- Home
- PROK vs LARK Comparison
PROK vs LARK Comparison
Compare PROK & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- LARK
- Stock Information
- Founded
- PROK 2015
- LARK 1885
- Country
- PROK United States
- LARK United States
- Employees
- PROK N/A
- LARK N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- LARK Major Banks
- Sector
- PROK Health Care
- LARK Finance
- Exchange
- PROK Nasdaq
- LARK Nasdaq
- Market Cap
- PROK 126.8M
- LARK 151.8M
- IPO Year
- PROK N/A
- LARK N/A
- Fundamental
- Price
- PROK $1.02
- LARK $29.61
- Analyst Decision
- PROK Buy
- LARK
- Analyst Count
- PROK 4
- LARK 0
- Target Price
- PROK $5.00
- LARK N/A
- AVG Volume (30 Days)
- PROK 1.3M
- LARK 29.5K
- Earning Date
- PROK 05-09-2025
- LARK 05-05-2025
- Dividend Yield
- PROK N/A
- LARK 2.75%
- EPS Growth
- PROK N/A
- LARK 6.15
- EPS
- PROK N/A
- LARK 2.26
- Revenue
- PROK $76,000.00
- LARK $58,168,000.00
- Revenue This Year
- PROK N/A
- LARK N/A
- Revenue Next Year
- PROK N/A
- LARK N/A
- P/E Ratio
- PROK N/A
- LARK $13.50
- Revenue Growth
- PROK N/A
- LARK 3.55
- 52 Week Low
- PROK $0.46
- LARK $17.05
- 52 Week High
- PROK $4.44
- LARK $31.04
- Technical
- Relative Strength Index (RSI)
- PROK 60.91
- LARK 64.42
- Support Level
- PROK $0.66
- LARK $25.51
- Resistance Level
- PROK $0.89
- LARK $31.04
- Average True Range (ATR)
- PROK 0.17
- LARK 1.40
- MACD
- PROK 0.06
- LARK 0.25
- Stochastic Oscillator
- PROK 77.78
- LARK 74.14
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four-family residential real estate, construction and land, commercial real estate, commercial, agriculture, municipal and consumer loans. In addition, it also invests in certain investment and mortgage related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.